D. E. Shaw & Co., Inc. Myriad Genetics Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,151,385 shares of MYGN stock, worth $15.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,151,385

Holding current value

$15.8 Million

% of portfolio

0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $590,572 - $704,646	24,638 Added 2.19%	1,151,385 $31.5 Million
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $2.51 Million - $3.55 Million	-139,366 Reduced 11.01%	1,126,747 $27.6 Million
Q1 2024 May 15, 2024	SELL	$17.59 - $23.59 $9.41 Million - $12.6 Million	-535,193 Reduced 29.71%	1,266,113 $27 Million
Q4 2023 Feb 14, 2024	SELL	$13.91 - $21.32 $5.24 Million - $8.03 Million	-376,619 Reduced 17.29%	1,801,306 $34.5 Million
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $2.41 Million - $3.5 Million	150,903 Added 7.44%	2,177,925 $34.9 Million
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $784,879 - $1.06 Million	44,697 Added 2.25%	2,027,022 $47 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $1.91 Million - $2.97 Million	125,025 Added 6.73%	1,982,325 $46 Million
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $1.46 Million - $2.12 Million	100,834 Added 5.74%	1,857,300 $26.9 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $5.18 Million - $7.93 Million	-284,394 Reduced 13.94%	1,756,466 $33.5 Million
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $2.54 Million - $3.99 Million	154,286 Added 8.18%	2,040,860 $37.1 Million
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $476,750 - $589,050	-21,030 Reduced 1.1%	1,886,574 $47.5 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $2.44 Million - $3.3 Million	-101,258 Reduced 5.04%	1,907,604 $52.7 Million
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $7.01 Million - $8.57 Million	-233,807 Reduced 10.43%	2,008,862 $64.9 Million
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $10.6 Million - $13.6 Million	-417,038 Reduced 15.68%	2,242,669 $68.6 Million
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $11.1 Million - $17.6 Million	-555,742 Reduced 17.28%	2,659,707 $81 Million
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $2.41 Million - $3.91 Million	-197,964 Reduced 5.8%	3,215,449 $63.6 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $1.4 Million - $1.83 Million	124,083 Added 3.77%	3,413,413 $44.5 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $6.51 Million - $10 Million	609,172 Added 22.73%	3,289,330 $37.3 Million
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $1.84 Million - $5.56 Million	-188,256 Reduced 6.56%	2,680,158 $38.4 Million
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $7.63 Million - $12.8 Million	364,645 Added 14.56%	2,868,414 $78.1 Million
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $18.1 Million - $38.6 Million	-819,327 Reduced 24.66%	2,503,769 $71.7 Million
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $11.9 Million - $18.3 Million	-523,346 Reduced 13.61%	3,323,096 $92.3 Million
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $2.06 Million - $2.65 Million	-76,410 Reduced 1.95%	3,846,442 $128 Million
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $813,469 - $1.36 Million	29,874 Added 0.77%	3,922,852 $114 Million
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $5.93 Million - $7.94 Million	-157,755 Reduced 3.89%	3,892,978 $179 Million
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $3.68 Million - $5.33 Million	-132,682 Reduced 3.17%	4,050,733 $151 Million
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $16.5 Million - $23.5 Million	-573,174 Reduced 12.05%	4,183,415 $124 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $3.11 Million - $4.06 Million	-109,314 Reduced 2.25%	4,756,589 $163 Million
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $117 Million - $176 Million	4,865,903	4,865,903 $176 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account